WARRANTTCP-ASC ACHI Series LLLP • February 16th, 2016 • Services-management services • Delaware
Company FiledFebruary 16th, 2016 Industry JurisdictionAccretive Health, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, TCP-ASC ACHI Series LLLP or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of 60,000,000 shares of common stock, $0.01 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an initial exercise price equal to $3.50 per share, at any time during the period (the “Exercise Period”) commencing on the date hereof and terminating at 5:00 p.m., New York time on February 16, 2026 (the “Expiration Date”). This Warrant (this “Warrant”) is issued pursuant to that certain Securities Purchase Agreement, dated as of December 7, 2015, by and among the Company, TCP-ASC ACHI Series LLLP, a Delaware limited liability limited partnership, and solely for purposes of the sections of such agreement specified therein, Ascension Health Alliance d/b/a Ascension Health (the “Pu
REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT $200 Million Aggregate Principal Amount 8% Series A Convertible Preferred StockRegistration Rights Agreement • February 16th, 2016 • TCP-ASC ACHI Series LLLP • Services-management services • Delaware
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionRegistration Rights Agreement (this “Agreement”), dated as of February 16, 2016, by and among Accretive Health, Inc., a Delaware corporation (the “Company”), TCP-ASC ACHI Series LLLP, a Delaware limited liability limited partnership (together with its Permitted Transferees, collectively, the “Investor”).
INVESTOR RIGHTS AGREEMENT INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 16th, 2016 • TCP-ASC ACHI Series LLLP • Services-management services • Delaware
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionInvestor Rights Agreement, dated as of February 16, 2016 (the “Agreement”), by and among Accretive Health, Inc., a Delaware corporation (the “Company”), TCP-ASC ACHI Series LLLP, a Delaware limited liability limited partnership (the “Investor”) and, solely for purposes of Section 4, Section 6 and Section 11, the undersigned Investor Affiliates.
Limited Liability Limited Partnership AgreementSeparate Series Agreement • February 16th, 2016 • TCP-ASC ACHI Series LLLP • Services-management services • Delaware
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionThis LIMITED LIABILITY LIMITED PARTNERSHIP AGREEMENT (as amended or restated from time to time, this “Agreement”), dated as of December 7, 2015 (the “Effective Date”), of TCP-ASC ACHI Series LLLP, a Delaware limited liability limited partnership with separate series (the “Partnership”), is by and among (i) the General Partner (as defined herein), which, as of the Effective Date, is TCP-ASC GP, LLC, a Delaware limited liability company (the “General Partner”) and (ii) each of the Limited Partners (as defined herein).
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2016 • TCP-ASC ACHI Series LLLP • Services-management services
Contract Type FiledFebruary 16th, 2016 Company IndustryThis Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.